BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Niu L, Sulek K, Vasilopoulou CG, Santos A, Wewer Albrechtsen NJ, Rasmussen S, Meier F, Mann M. Defining NASH from a Multi-Omics Systems Biology Perspective. J Clin Med 2021;10:4673. [PMID: 34682795 DOI: 10.3390/jcm10204673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rajak S, Tewari A, Raza S, Gupta P, Chakravarti B, Anjum B, Tripathi M, Singh BK, Yen PM, Goel A, Ghosh S, Sinha RA. Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice. Biochim Biophys Acta Mol Basis Dis 2023;1869:166662. [PMID: 36754244 DOI: 10.1016/j.bbadis.2023.166662] [Reference Citation Analysis]
2 Wang MX, Luo W, Ye L, Jin LM, Yang B, Zhang QH, Qian JC, Wang Y, Zhang Y, Liang G. Dectin-1 plays a deleterious role in high fat diet-induced NAFLD of mice through enhancing macrophage activation. Acta Pharmacol Sin 2023;44:120-32. [PMID: 35689091 DOI: 10.1038/s41401-022-00926-2] [Reference Citation Analysis]
3 Sakallioglu IT, Tripp B, Kubik J, Casey CA, Thomes P, Powers R. Multiomics Approach Captures Hepatic Metabolic Network Altered by Chronic Ethanol Administration. Biology (Basel) 2022;12. [PMID: 36671721 DOI: 10.3390/biology12010028] [Reference Citation Analysis]
4 Martinou E, Pericleous M, Stefanova I, Kaur V, Angelidi AM. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics (Basel) 2022;12:407. [PMID: 35204498 DOI: 10.3390/diagnostics12020407] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]